The CoWIN platform and Aarogya Setu App will open the registration for COVID-19 vaccines for all ages above 18 on 28 April, officials said Thursday.
The process of inoculation and the documents to be submitted are the same
PROCESS:
In the third stage of the inoculation drive, the Central Government announced that vaccinations in excess of the age of 18 will commence throughout the country from 1 May 2015.
There have been some amendments, including the age criteria and some other features, and the CoWIN platform is ready, as the vaccination for all is being launched, to meet growing demand.
From 1 May, the existing system of privately owned vaccination centres COVID-19 receiving state doses and charging up to Rs 250 per dose will cease, and the vaccine manufacturers will receive private hospitals directly.
The vaccination strategy COVID-19 is free for eligible population groups of health workers, front-line workers, and people over 45 at state vaccination centres, which receive doses from the Government of India, according to the Liberal Pricing and Accelerated National Vaccination Strategy COVID-19.
Vaccine manufacturers would issue a 50% advance price declaration that would be available in the open market for state governments before May 1.
According to this price, manufacturers can acquire vaccine doses from states, private hospitals and industrial institutions.
SUPPLY OF VACCINES:
The supply of COVID-19 vaccines to private hospitals should be exclusively from the 50% supply for the Indian channel other than the government.
“It does not mean that vaccinations are sold in pharmaceutical or chemist shops in the open market while the Centre’s vaccination policy has been liberalised,” said Secretary Rajesh Bhushan on Wednesday.
He said that the cost of private hospital vaccinations would be monitored.
“It will no longer be possible for private COVID vaccination centres to receive government doses and charge up to Rs 250 per dose,” the Minister of Health of the Union said.
Vaccine companies supply 50% of their monthly doses released to the government of India by the Central Drug Laboratory (CDL), and are free to supply State and open markets with the remaining 50% dosages.
Eligible people, which currently exist, i.e. healthcare workers (HCWs), frontline workers (FLWs) and the population over 40 years of age, would be the same for Indian government vaccination centres.
ELIGIBILITY
The eligibility would be for every adult citizen of the country, other than the government of India, according to the document.
In all of COVID vaccination centres, which receive central government vaccine doses, eligible population groups will continue to receive vaccine-free COVID-19 vaccination.
VACCINATION SYSTEM
The whole vaccination system will take the form of a National Vaccination Programme, follow all existing guidelines and be captured on the CoWIN platform together with the inventory and vaccine cost applicable to all vaccination centres, and will comply with the Adverse Event Following Immunization Management (AEFI) programme.
For all the vaccines produced within that country, the division of the supply of vaccines, which would make 50% of India’s government and 50% other than India’s government, would apply uniformly.
However, it said that it would be permitted to use the fully ready-to-use imported vaccine entirely other than India.
Second dose of all priorities already existing, i.e. Specific and focused strategy would be communicated to all stakeholders wherever appropriate to HCWs, FLWs, and people over 45 years of age.
This policy is effective from 1 May and is subject to regular review.
